Physician profile
Farshid Daneshvar
NPI 1477817823
$3,348.17
in general payments reported to CMS, 2019-2025
17 companies · $367 in 2025
The $367 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $9.09 · 2021: $54.35 · 2022: $448 · 2023: $310 · 2024: $2,160 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539 · Travel and Lodging: $1,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,539.38 |
| Travel and Lodging | $1,297.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,831.37 | 2024 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $267.66 | 2022-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $193.92 | 2022-2023 | Xarelto |
| Abbott Laboratories | $175.08 | 2022-2024 | Supera |
| Abiomed | $147.40 | 2024 | Impella |
| Medtronic, INC. | $145.72 | 2021-2023 | Hawkone |
| Cvrx, INC. | $140.25 | 2025 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $128.35 | 2025 | Assure Wcd |
| Inari Medical, INC. | $97.27 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $51.80 | 2022-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $39.20 | 2021-2023 | Farxiga |
| Angiodynamics, INC. | $38.43 | 2025 | Auryon Laser System 100-120 Vac |
| Novartis Pharmaceuticals Corporation | $33.39 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $17.67 | 2021 | |
| Lantheus Medical Imaging, INC. | $15.83 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.74 | 2025 | |
| Cardiovascular Systems INC. | $9.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farshid Daneshvar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.